These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6311002)

  • 1. Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and and in vivo.
    Cleeland R; Squires E
    Am J Med; 1983 Aug; 75(2A):21-9. PubMed ID: 6311002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of amdinocillin in combination with other beta-lactam antibiotics against aminoglycoside-susceptible and resistant gram-negative bacteria.
    Nachamkin I; Gibson G; Sawyer K; Samel C; Skalina D
    Diagn Microbiol Infect Dis; 1988 Feb; 9(2):87-96. PubMed ID: 3383549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of mecillinam alone and in combination with other beta-lactam antibiotics.
    Fass RJ
    Antimicrob Agents Chemother; 1980 Dec; 18(6):906-12. PubMed ID: 6263179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic changes produced by amdinocillin alone and in combination with beta-lactam antibiotics: in vitro and in vivo.
    Kramer MJ; Mauriz YR; Timmes MD; Robertson TL; Cleeland R
    Am J Med; 1983 Aug; 75(2A):30-41. PubMed ID: 6311003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amdinocillin: interaction with other beta-lactam antibiotics for gram-negative bacteria.
    Eng RH; Liu R; Smith SM; Johnson ES; Cherubin CE
    Chemotherapy; 1988; 34(1):18-26. PubMed ID: 3258230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penicillin-binding proteins and role of amdinocillin in causing bacterial cell death.
    Neu HC
    Am J Med; 1983 Aug; 75(2A):9-20. PubMed ID: 6311012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the enhancement of beta-lactam activity by amdinocillin in a model of the human urinary bladder.
    Anderson JD; Eftekhar F
    Am J Med; 1983 Aug; 75(2A):42-7. PubMed ID: 6311004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative clinical laboratory study of a broth-disk test for determination of bacterial susceptibility to beta-lactams in combination with amdinocillin.
    Isenberg HD; Tilton RC; Barry AL; Beskid G; Cleeland R; Fallat V; Murray PR; Pierson C; Squires E
    J Clin Microbiol; 1987 Jul; 25(7):1195-200. PubMed ID: 3611312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic infections treated with amdinocillin in combination with other beta-lactam antibiotics.
    King JW; Beam TR; Neu HC; Smith LG
    Am J Med; 1983 Aug; 75(2A):90-5. PubMed ID: 6311013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
    Goto S
    Rev Infect Dis; 1982; 4 Suppl():S501-10. PubMed ID: 6218559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.
    Fass RJ
    Antimicrob Agents Chemother; 1982 Jan; 21(1):188-91. PubMed ID: 6282206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
    Fass RJ
    Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections.
    Isenberg HD; Sampson-Scherer J; Cleeland R; Titsworth E; Beskid G; Christenson JG; DeLorenzo WF; Unowsky J
    Crit Rev Microbiol; 1982; 10(1):1-76. PubMed ID: 6756787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro interaction between mecillinam and piperacillin-tazobactam in the presence of azithromycin against members of the Enterobacteriaceae family and Pseudomonas aeruginosa.
    Maioli E; Debbia EA; Gualco L; Marchese A
    New Microbiol; 2008 Jan; 31(1):37-46. PubMed ID: 18437840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic considerations in using combinations of newer beta-lactam antibiotics.
    Barriere SL
    Clin Pharm; 1986 Jan; 5(1):24-33. PubMed ID: 3512153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amdinocillin therapy of experimental animal infections.
    Gordin FM; Sande MA
    Am J Med; 1983 Aug; 75(2A):48-53. PubMed ID: 6311005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amdinocillin: a novel penicillin. Antibacterial activity, pharmacology and clinical use.
    Neu HC
    Pharmacotherapy; 1985; 5(1):1-10. PubMed ID: 3885172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy and mecillinam.
    Gray J
    J Antimicrob Chemother; 1977 Nov; 3(6):531-3. PubMed ID: 202586
    [No Abstract]   [Full Text] [Related]  

  • 20. Amdinocillin in combination with beta-lactam antibiotics for treatment of serious gram-negative infections.
    Rotstein C; Farrar WE
    Am J Med; 1983 Aug; 75(2A):96-9. PubMed ID: 6311014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.